Mesoatrial Shunt for Budd-Chiari Syndrome

Guang-Chang Zhu(Second Artillery General Hospital of Chinese People's Liberation Army), Chao Ma(Beijing Normal University), Guo-Feng Hou(Beijing Normal University), Zhonggao Wang(Capital Medical University), Jianwei Zhang(Capital Medical University), Wei Guo(First Affiliated Hospital of Xiamen University), Zhiwei Hu(Beijing Normal University), Ce Bian(Sichuan University)
Annals of Vascular Surgery
July 21, 2017
10.1016/j.avsg.2017.07.020
Cited by 1

Related Papers

Global vascular guidelines on the management of chronic limb-threatening ischemia
|Journal of Vascular Surgery|2019|1.9k
Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia
|European Journal of Vascular and Endovascular Surgery|2019|1.5k
Neoadjuvant PD-1 blockade with toripalimab, with or without celecoxib, in mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): a single-centre, parallel-group, non-comparative, randomised, phase 2 trial
|˜The œLancet. Gastroenterology & hepatology|2021|304
<p>m<sup>6</sup>A methyltransferase METTL3 suppresses colorectal cancer proliferation and migration through p38/ERK pathways</p>
|OncoTargets and Therapy|2019|164
Regulation of endothelial thrombomodulin expression by inflammatory cytokines is mediated by activation of nuclear factor-kappa B
|Blood|2005|112